English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Fareston (toremifene) – Labelling - L02BA02

Updated on site: 06-Oct-2017

Medication nameFareston
ATC CodeL02BA02
Substancetoremifene
ManufacturerOrion Corporation

PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING

OUTER CARTON 30 TABLETS

1.NAME OF THE MEDICINAL PRODUCT

Fareston 60 mg tablets toremifene

2.STATEMENT OF ACTIVE SUBSTANCE(S)

Each tablet contains 60 mg toremifene (as citrate)

3.LIST OF EXCIPIENTS

Excipients: contains lactose. See package leaflet for further information.

4.PHARMACEUTICAL FORM AND CONTENTS

30 tablets

5.METHOD AND ROUTE(S) OF ADMINISTRATION

Read the package leaflet before use.

6.SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN

Keep out of the sight and reach of children.

7.OTHER SPECIAL WARNING(S), IF NECESSARY

8.EXPIRY DATE

EXP:

9.SPECIAL STORAGE CONDITIONS

10.SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE

11.NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER

ORION CORPORATION

Orionintie 1

FIN-02200 ESPOO

FINLAND

12.MARKETING AUTHORISATION NUMBER(S)

EU/1/96/004/001

13.BATCH NUMBER

Batch number:

14.GENERAL CLASSIFICATION FOR SUPPLY

Medicinal product subject to medical prescription.

15.INSTRUCTIONS ON USE

16.INFORMATION IN BRAILLE

Fareston 60 mg

PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING

OUTER CARTON 100 TABLETS

1. NAME OF THE MEDICINAL PRODUCT

Fareston 60 mg tablets toremifene

2. STATEMENT OF ACTIVE SUBSTANCE(S)

Each tablet contains 60 mg toremifene (as citrate)

3. LIST OF EXCIPIENTS

Excipients: contains lactose. See package leaflet for further information

4. PHARMACEUTICAL FORM AND CONTENTS

100 tablets

5. METHOD AND ROUTE(S) OF ADMINISTRATION

Read the package leaflet before use.

6. SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN

Keep out of the sight and reach of children.

7. OTHER SPECIAL WARNING(S), IF NECESSARY

8. EXPIRY DATE

EXP:

9. SPECIAL STORAGE CONDITIONS

10. SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE

11. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER

ORION CORPORATION

Orionintie 1

FIN-02200 ESPOO

FINLAND

12. MARKETING AUTHORISATION NUMBER(S)

EU/1/96/004/002

13. BATCH NUMBER

Batch number:

14. GENERAL CLASSIFICATION FOR SUPPLY

Medicinal product subject to medical prescription.

15. INSTRUCTIONS ON USE

16. INFORMATION IN BRAILLE

Fareston 60 mg

MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS

BLISTER

1.NAME OF THE MEDICINAL PRODUCT

Fareston 60 mg tablets toremifene

2.NAME OF THE MARKETING AUTHORISATION HOLDER

ORION CORPORATION

3.EXPIRY DATE

EXP:

4.BATCH NUMBER

Batch number:

5.OTHER

Comments

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Help
  • Get it on Google Play
  • About
  • Info on site by:

  • Presented by RXed.eu

  • 27558

    prescription drugs listed